aCGT Vector

aCGT Vector is an Irish private cell therapy company focused on expanding patient access to precision medicines through a distributed, hospital-based advanced therapy manufacturing model. The company is developing a digitized therapies-as-a-service platform built around closed-system, GMP-compliant ATMP "POD" facilities located proximal to patients. Its work centers on autologous and other cellular therapy workflows, with applications in cancer and rare diseases, and it has also referenced RNA vaccine capabilities. Rather than being a traditional drug developer with a disclosed clinical pipeline, aCGT Vector appears primarily oriented toward enabling development, clinical delivery, and future commercialization infrastructure for advanced therapies. The company has partnered with Xcell Biosciences to combine its manufacturing platform with analytical and process-optimization tools for cell and gene therapy development.